2. Search Result
Search Result
Results for "

mPEG

" in MedChemExpress (MCE) Product Catalog:

319

Inhibitors & Agonists

1

Fluorescent Dye

49

Biochemical Assay Reagents

1

Peptides

31

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-400145
    mPEG45-Epoxide

    		PROTAC Linkers Others
    mPEG45-Epoxide is a PEG derivative containing polyether units. mPEG45-Epoxide can be used to synthesize PROTAC molecules .
    <em>mPEG</em>45-Epoxide
  • HY-400147
    mPEG45-diol

    		PROTAC Linkers Cancer
    mPEG45-diol is a PEG derivative containing polyether units. mPEG45-Epoxide is a PROTAC linker can be used to synthesize PROTAC molecules .
    <em>mPEG</em>45-diol
  • HY-124011
    m-PEG3-aldehyde

    		PROTAC Linkers Cancer
    m-PEG3-aldehyde is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
    m-PEG3-aldehyde
  • HY-140676
    mPEG-amine (MW 2000)

    mPEG-NH2 (MW 2000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 2000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 2000)
  • HY-140677
    mPEG-amine (MW 5000)

    mPEG-NH2 (MW 5000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 5000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 5000)
  • HY-140678
    mPEG-amine (MW 10000)

    mPEG-NH2 (MW 10000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 10000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 10000)
  • HY-155918
    mPEG-CHO (MW 1000)

    mPEG-Aldehyde (MW 1000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 1000)
  • HY-155915
    mPEG-CHO (MW 350)

    mPEG-Aldehyde (MW 350)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 350) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 350)
  • HY-155916
    mPEG-CHO (MW 550)

    mPEG-Aldehyde (MW 550)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 550) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 550)
  • HY-155917
    mPEG-CHO (MW 750)

    mPEG-Aldehyde (MW 750)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 750) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 750)
  • HY-155919
    mPEG-CHO (MW 2000)

    mPEG-Aldehyde (MW 2000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 2000)
  • HY-155920
    mPEG-CHO (MW 3400)

    mPEG-Aldehyde (MW 3400)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 3400) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 3400)
  • HY-155921
    mPEG-CHO (MW 5000)

    mPEG-Aldehyde (MW 5000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 5000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 5000)
  • HY-155922
    mPEG-CHO (MW 10000)

    mPEG-Aldehyde (MW 10000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 10000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 10000)
  • HY-155923
    mPEG-CHO (MW 20000)

    mPEG-Aldehyde (MW 20000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 20000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 20000)
  • HY-158255
    mPEG-PLGA (2000-80000) (LA/GA 50:50)

    		Biochemical Assay Reagents Others
    mPEG-PLGA (2000-80000) (LA/GA 50:50) is a copolymer, which consists of hydrophilic mPEG and biodegradable PLGA (molar ratio is 50:50) with a molecular weight of 2000 (mPEG) + 80000 (PLGA). mPEG-PLGA (2000-80000) (LA/GA 50:50) forms nanoparticles or microparticles, which is stable in aqueous solution at different pH values and elevated temperatures as well as in serum. mPEG-PLGA (2000-80000) (LA/GA 50:50) is utilized as carrier material in drug delivery systems .
    <em>mPEG</em>-PLGA (2000-80000) (LA/GA 50:50)
  • HY-W020780
    mPEG-Mal (MW 5000)

    mPEG-Maleimide (MW 5000); Methoxypolyethylene glycol maleimide (MW 5000)

    		 Biochemical Assay Reagents Others
    mPEG-Mal (MW 5000) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    <em>mPEG</em>-Mal (MW 5000)
  • HY-RS08610
    MPEG1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    MPEG1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPEG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MPEG1 Human Pre-designed siRNA Set A
    MPEG1 Human Pre-designed siRNA Set A
  • HY-W440931
    MPEG2000-DMG

    		Liposome Cancer
    MPEG2000-DMG is a liposome to simulate biological phospholipid membrane. Liposomes are the main component of vesicles with concentric phospholipid bilayer membranes, which can be used to construct drug delivery systems for anti-cancer and anti-infection fields. Highly polar water-soluble payloads can be trapped in the internal aqueous space of liposomes, while lipophilic payloads can partition into and become part of the lipid bilayer. Especially for delivering antisense oligonucleotides, it can overcome problems such as inefficient cellular uptake and rapid loss in the body .
    <em>MPEG</em>2000-DMG
  • HY-W020780A
    mPEG-Mal (MW 350)

    mPEG-Maleimide (MW 350); Methoxypolyethylene glycol maleimide (MW 350)

    		 Biochemical Assay Reagents Others
    mPEG-Mal (MW 350) is a PEG derivative used for thiol PEGylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 350)
  • HY-W020780B
    mPEG-Mal (MW 750)

    mPEG-Maleimide (MW 750); Methoxypolyethylene glycol maleimide (MW 750)

    		 Biochemical Assay Reagents Others
    mPEG-Mal (MW 750) is a PEG derivative used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 750)
  • HY-W020780C
    mPEG-Mal (MW 3400)

    mPEG-Maleimide (MW 3400); Methoxypolyethylene glycol maleimide (MW 3400)

    		 Biochemical Assay Reagents Others
    mPEG-Mal (MW 3400) is a PEG derivative used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 3400)
  • HY-155880
    mPEG-amine (MW 350)

    mPEG-NH2 (MW 350)

    		 Biochemical Assay Reagents Cancer
    mPEG-amine (MW 350) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 350)
  • HY-155881
    mPEG-amine (MW 550)

    mPEG-NH2 (MW 550)

    		 Biochemical Assay Reagents Cancer
    mPEG-amine (MW 550) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 550)
  • HY-155882
    mPEG-amine (MW 750)

    mPEG-NH2 (MW 750)

    		 Biochemical Assay Reagents Cancer
    mPEG-amine (MW 750) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 750)
  • HY-155883
    mPEG-amine (MW 3400)

    mPEG-NH2 (MW 3400)

    		 Biochemical Assay Reagents Cancer
    mPEG-amine (MW 3400) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 3400)
  • HY-155884
    mPEG-amine (MW 4000)

    mPEG-NH2 (MW 4000)

    		 Biochemical Assay Reagents Cancer
    mPEG-amine (MW 4000) can be used to synthesize folate-conjugated polymer micelles for encapsulating anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 4000)
  • HY-W590593
    mPEG-Cholesterol,MW 2000

    		Liposome Cancer
    mPEG-Cholesterol,MW 2000 is a liposome to simulate biological phospholipid membrane. Liposomes are the main component of vesicles with concentric phospholipid bilayer membranes, which can be used to construct drug delivery systems for anti-cancer and anti-infection fields. Highly polar water-soluble payloads can be trapped in the internal aqueous space of liposomes, while lipophilic payloads can partition into and become part of the lipid bilayer. Especially for delivering antisense oligonucleotides, it can overcome problems such as inefficient cellular uptake and rapid loss in the body .
    <em>mPEG</em>-Cholesterol,MW 2000
  • HY-W591476
    m-PEG-thiol (MW 1000)

    mPEG-SH (MW 1000)

    		 Biochemical Assay Reagents Others
    m-PEG-thiol (MW 1000) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 1000)
  • HY-W591476A
    m-PEG-thiol (MW 3400)

    mPEG-SH (MW 3400)

    		 Biochemical Assay Reagents Others
    m-PEG-thiol (MW 3400) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 3400)
  • HY-W591476B
    m-PEG-thiol (MW 750)

    mPEG-SH (MW 750)

    		 Biochemical Assay Reagents Others
    m-PEG-thiol (MW 750) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 750)
  • HY-W591476C
    m-PEG-thiol (MW 550)

    mPEG-SH (MW 550)

    		 Biochemical Assay Reagents Others
    m-PEG-thiol (MW 550) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 550)
  • HY-W591476D
    m-PEG-thiol (MW 350)

    mPEG-SH (MW 350)

    		 Biochemical Assay Reagents Others
    m-PEG-thiol (MW 350) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 350)
  • HY-139819
    MPEG-PLA (PEG MW 3000 & PLA MW 50,000)

    		Biochemical Assay Reagents Others
    MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer, which can be used to preparenanoparticles for targeted drug delivery .
    <em>MPEG</em>-PLA (PEG MW 3000 & PLA MW 50,000)
  • HY-140675
    mPEG-amine (MW 1000)

    mPEG-NH2 (MW 1000)

    		 PROTAC Linkers Cancer
    m-PEG-NH2 (MW 1000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 1000)
  • HY-140679
    mPEG-amine (MW 20000)

    mPEG-NH2 (MW 20000)

    		 PROTAC Linkers Cancer
    m-PEG-NH2 (MW 20000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 20000)
  • HY-140698
    m-PEG-NHS ester (MW 5000)

    mPEG-SC (MW 5000); mPEG-Succinimidyl ester (MW 5000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 5000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 5000)
  • HY-140699
    m-PEG-NHS ester (MW 10000)

    mPEG-SC (MW 10000); mPEG-Succinimidyl ester (MW 10000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 10000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 10000)
  • HY-140700
    m-PEG-NHS ester (MW 20000)

    mPEG-SC (MW 20000); mPEG-Succinimidyl ester (MW 20000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 20000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 20000)
  • HY-155909
    m-PEG-NHS ester (MW 3400)

    mPEG-SC (MW 3400); mPEG-Succinimidyl ester (MW 3400)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 3400) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 3400)
  • HY-155909A
    m-PEG-NHS ester (MW 1000)

    mPEG-SC (MW 1000); mPEG-Succinimidyl ester (MW 1000)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 1000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 1000)
  • HY-155909B
    m-PEG-NHS ester (MW 550)

    mPEG-SC (MW 550); mPEG-Succinimidyl ester (MW 550)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 550) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 550)
  • HY-155909C
    m-PEG-NHS ester (MW 350)

    mPEG-SC (MW 350); mPEG-Succinimidyl ester (MW 350)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 350) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 350)
  • HY-W591424
    m-PEG-NHS ester (MW 2000)

    mPEG-SC (MW 2000); mPEG-Succinimidyl ester (MW 2000)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 2000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 2000)
  • HY-157745
    m-PEG-NHS ester (MW 40000)

    mPEG-SC (MW 40000); mPEG-Succinimidyl ester (MW 40000)

    		 Biochemical Assay Reagents Others
    m-PEG-NHS ester (MW 40000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects .
    m-PEG-NHS ester (MW 40000)
  • HY-120237
    m-PEG7-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG7-Amine
  • HY-130408
    m-PEG6-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG6-Amine
  • HY-130571
    m-PEG9-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG9-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG9-Amine
  • HY-42745
    m-PEG2-Tos

    		ADC Linker PROTAC Linkers Cancer
    m-PEG2-Tos is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG2-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
    m-PEG2-Tos
  • HY-W008429
    m-PEG2-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG2-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG2-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG2-Amine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: